The drugs are given by doctors in order to help treat or prevent a particular disease. However, what should restore people’s health can cause problems.
Last Sunday (01/26/20), ANVISA (National Health Surveillance Agency) decreed that the import of ranitidine input , produced by an Indian company called Saraca Laboratories Limited, be suspended.
The main reason for this attitude was the detection of high levels of N-nitrosodimethylamine (NDMA), a component that can be carcinogenic and cause health problems.
But after all, what is this medicine for and what is it for?
Continue reading to learn more about the suspension of the drug across the country.
Understand what pancreatitis is by clicking here!
What is ranitidine?
The ranitidine is a substance which helps to reduce the impact of the acid produced in the stomach and gastric secretion, reducing the symptoms of diseases such as reflux, gastritis and ulcer, in addition to promoting healing and prevent complications.
According to experts, it is not the drug that is offering health risks, but the substance NDMA, and because of that ANVISA asked that precautionary measures be taken to avoid major problems, since the substance may have a high potential carcinogenic.
In addition, it was also recommended that companies reevaluate the drug’s processing methods to avoid contamination. So far, 225 batches of this drug have been collected .
N-nitrosodimethylamine (NDMA): the risks
The NDMA is an environmental contaminant, which can be found easily in water and food, including mainly smoked and cooked.
Although the risks that this chemical component can cause to the human organism are not so well established, NDMA has been classified as a possible risk of developing cancer, and ranitidine is suspended as a way to prevent contamination that further harm health.
See how Crohn’s disease can be treated. Click here!
The main guideline is for consumers who are already on treatment to immediately consult a doctor , who should guide the patient to use other means, such as some therapeutic alternative to ranitidine.